請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16373
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳為堅,李永凌 | |
dc.contributor.author | Chien-Han Chen | en |
dc.contributor.author | 陳建翰 | zh_TW |
dc.date.accessioned | 2021-06-07T18:11:56Z | - |
dc.date.copyright | 2012-09-17 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-06-28 | |
dc.identifier.citation | 1. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118-27.
2. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006;118:152-69. 3. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999;104:S114-22. 4. Huang JL, Chen CC, Kuo ML, Hsieh KH. Exposure to a high concentration of mite allergen in early infancy is a risk factor for developing atopic dermatitis: a 3-year follow-up study. Pediatr Allergy Immunol 2001;12:11-6. 5. Kjellman NI, Croner S. Cord blood IgE determination for allergy prediction--a follow-up to seven years of age in 1,651 children. Ann Allergy 1984;53:167-71. 6. Sadeghnejad A, Karmaus W, Davis S, Kurukulaaratchy RJ, Matthews S, Arshad SH. Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10. Thorax 2004;59:936-42. 7. Chang W-T, Sun H-L, Lue K-H, Chou M-C. Predictability of early onset atopic dermatitis by cord blood IgE and parental history. Acta Paediatr Taiwan 2005;46:272-7. 8. Pesonen M, Kallio MJT, Siimes MA, Elg P, Bjorksten F, Ranki A. Cord serum immunoglobulin E as a risk factor for allergic symptoms and sensitization in children and young adults. Pediatr Allergy Immunol 2009;20:12-8. 9. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003;300:1527-8. 10. Kasaian MT, Miller DK. IL-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 2008;76:147-55. 11. Peters JL, Suglia SF, Platts-Mills TAE, Hosen J, Gold DR, Wright RJ. Relationships among prenatal aeroallergen exposure and maternal and cord blood IgE: project ACCESS. J Allergy Clin Immunol 2009;123:1041-6. 12. Scirica CV, Gold DR, Ryan L, et al. Predictors of cord blood IgE levels in children at risk for asthma and atopy. J Allergy Clin Immunol 2007;119:81-8. 13. Bergmann RL, Schulz J, Gunther S, et al. Determinants of cord-blood IgE concentrations in 6401 German neonates. Allergy 1995;50:65-71. 14. Scirica CV, Gold DR, Ryan L, et al. Predictors of cord blood IgE levels in children at risk for asthma and atopy. J Allergy Clin Immunol 2007;119:81-8. 15. Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105:506-13. 16. Kabesch M, Tzotcheva I, Carr D, et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003;112:893-8. 17. Duetsch G, Illig T, Loesgen S, et al. STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study. Hum Mol Genet 2002;11:613-21. 18. Deichmann K, Bardutzky J, Forster J, Heinzmann A, Kuehr J. Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 1997;231:696-7. 19. Hackstein H, Hecker M, Kruse S, et al. A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 2001;53:264-9. 20. Jacobsen HP, Herskind AM, Nielsen BW, Husby S. IgE in unselected like-sexed monozygotic and dizygotic twins at birth and at 6 to 9 years of age: high but dissimilar genetic influence on IgE levels. J Allergy Clin Immunol 2001;107:659-63. 21. Strachan DP, Wong HJ, Spector TD. Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J Allergy Clin Immunol 2001;108:901-7. 22. Yang KD, Ou CY, Hsu TY, et al. Interaction of maternal atopy, CTLA-4 gene polymorphism and gender on antenatal immunoglobulin E production. Clin Exp Allergy 2007;37:680-7. 23. Wen H-J, Lin Y-C, Lee Y-L, Guo YL. Association between cord blood IgE and genetic polymorphisms of interleukin-4, the beta-subunit of the high-affinity receptor for IgE, lymphotoxin-alpha, and tumor necrosis factor-alpha. Pediatr Allergy Immunol 2006;17:489-94. 24. Yang KD, Chang JC, Chuang H, et al. Gene-gene and gene-environment interactions on IgE production in prenatal stage. Allergy 2010;65:731-9. 25. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.[Erratum appears in Lancet. 2007 Sep 29;370(9593):1128]. Lancet 2006;368:733-43. 26. Polte T, Hennig C, Hansen G. Allergy prevention starts before conception: maternofetal transfer of tolerance protects against the development of asthma. J Allergy Clin Immunol 2008;122:1022-30.e5. 27. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. American Journal of Reproductive Immunology 1999;42:240-5. 28. Prescott SL. Effects of early cigarette smoke exposure on early immune development and respiratory disease. Paediatric Respiratory Reviews 2008;9:3–10. 29. Loibichler C, Pichler J, Gerstmayr M, et al. Materno-fetal passage of nutritive and inhalant allergens across placentas of term and pre-term deliveries perfused in vitro. Clin Exp Allergy 2002;32:1546-51. 30. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730-7. 31. Macaubas C, de Klerk NH, Holt BJ, et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet 2003;362:1192-7. 32. Noakes PS, Hale J, Thomas R, Lane C, Devadason SG, Prescott SL. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. Eur Respir J 2006;28:721-9. 33. Hertz-Picciotto I, Park H-Y, Dostal M, Kocan A, Trnovec T, Sram R. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic & Clinical Pharmacology & Toxicology 2008;102:146-54. 34. Chandra RK, Puri S, Cheema PS. Predictive value of cord blood IgE in the development of atopic disease and role of breast-feeding in its prevention. Clinical Allergy 1985;15:517-22. 35. Merrett TG, Burr ML, Butland BK, Merrett J, Miskelly FG, Vaughan-Williams E. Infant feeding and allergy: 12-month prospective study of 500 babies born into allergic families. Ann Allergy 1988;61:13-20. 36. Bergmann KE, Bergmann RL, Schulz J, Grass T, Wahn U. Prediction of atopic disease in the newborn: methodological aspects. Clin Exp Allergy 1990;20 Suppl 3:21-6. 37. Hansen LG, Host A, Halken S, et al. Cord blood IgE. II. Prediction of atopic disease. A follow-up at the age of 18 months. Allergy 1992;47:397-403. 38. Hansen LG, Host A, Halken S, et al. Cord blood IgE. III. Prediction of IgE high-response and allergy. A follow-up at the age of 18 months. Allergy 1992;47:404-10. 39. Tariq SM, Arshad SH, Matthews SM, Hakim EA. Elevated cord serum IgE increases the risk of aeroallergen sensitization without increasing respiratory allergic symptoms in early childhood. Clin Exp Allergy 1999;29:1042-8. 40. Lilja G, Johansson SG, Kusoffsky E, Oman H. IgE levels in cord blood and at 4-5 days of age: relation to clinical symptoms of atopic disease up to 18 months of age. Allergy 1990;45:436-44. 41. Kaan A, Dimich-Ward H, Manfreda J, et al. Cord blood IgE: its determinants and prediction of development of asthma and other allergic disorders at 12 months. Ann Allergy Asthma Immunol 2000;84:37-42. 42. Wen H-J, Wang Y-J, Lin Y-C, et al. Prediction of atopic dermatitis in 2-yr-old children by cord blood IgE, genetic polymorphisms in cytokine genes, and maternal mentality during pregnancy. Pediatr Allergy Immunol 2011;22:695-703. 43. Edenharter G, Bergmann RL, Bergmann KE, et al. Cord blood-IgE as risk factor and predictor for atopic diseases. Clin Exp Allergy 1998;28:671-8. 44. Bergmann RL, Edenharter G, Bergmann KE, et al. Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy 1997;27:752-60. 45. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med 2006;354:1166-76. 46. Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94. 47. Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004;169:70-6. 48. Sugiyama M, Arakawa H, Ozawa K, et al. Early-life risk factors for occurrence of atopic dermatitis during the first year. Pediatrics 2007;119:e716-23. 49. Ohshima Y, Yasutomi M, Omata N, et al. Dysregulation of IL-13 production by cord blood CD4+ T cells is associated with the subsequent development of atopic disease in infants. Pediatric Research 2002;51:195-200. 50. Lange J, Ngoumou G, Berkenheide S, et al. High interleukin-13 production by phytohaemagglutinin- and Der p 1-stimulated cord blood mononuclear cells is associated with the subsequent development of atopic dermatitis at the age of 3 years. Clin Exp Allergy 2003;33:1537-43. 51. Neaville WA, Tisler C, Bhattacharya A, et al. Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. J Allergy Clin Immunol 2003;112:740-6. 52. Warner JA, Miles EA, Jones AC, Quint DJ, Colwell BM, Warner JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994;24:423-30. 53. Sharp MJ, Rowe J, Kusel M, Sly PD, Holt PG. Specific patterns of responsiveness to microbial antigens staphylococcal enterotoxin B and purified protein derivative by cord blood mononuclear cells are predictive of risk for development of atopic dermatitis. Clin Exp Allergy 2003;33:435-41. 54. Maurer M, von Stebut E. Macrophage inflammatory protein-1. International Journal of Biochemistry & Cell Biology 2004;36:1882-6. 55. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-604. 56. Grob M, Schmid-Grendelmeier P, Joller-Jemelka HI, et al. Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma. Allergy 2003;58:239-45. 57. Sala-Vila A, Miles EA, Calder PC. Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined. Clin Exp Allergy 2008;38:1432-50. 58. Galland L. Increased requirements for essential fatty acids in atopic individuals: a review with clinical descriptions. Journal of the American College of Nutrition 1986;5:213-28. 59. Calder PC, Miles EA. Fatty acids and atopic disease. Pediatr Allergy Immunol 2000;11 Suppl 13:29-36. 60. Duchen K, Bjorksten B. Polyunsaturated n-3 fatty acids and the development of atopic disease. Lipids 2001;36:1033-42. 61. Guilliams TG. The use of fish oil supplements in clinical practice: a review. The Journal of the American Nutraceutical Association 2005;8:21-34. 62. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J 1997;10:6-12. 63. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. British Journal of Nutrition 2002;87 Suppl 1:S31-48. 64. Dunstan JA, Mori TA, Barden A, et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 2003;33:442-8. 65. Sausenthaler S, Koletzko S, Schaaf B, et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. American Journal of Clinical Nutrition 2007;85:530-7. 66. Romieu I, Torrent M, Garcia-Esteban R, et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clin Exp Allergy 2007;37:518-25. 67. Willers SM, Devereux G, Craig LCA, et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax 2007;62:773-9. 68. Byberg K, Oymar K, Aksnes L. Fatty acids in cord blood plasma, the relation to soluble CD23 and subsequent atopy. Prostaglandins Leukotrienes & Essential Fatty Acids 2008;78:61-5. 69. Hibbert RG, Teriete P, Grundy GJ, et al. The structure of human CD23 and its interactions with IgE and CD21. Journal of Experimental Medicine 2005;202:751-60. 70. Galli E, Picardo M, Chini L, et al. Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease? British Journal of Dermatology 1994;130:752-6. 71. Yu G, Kjellman NI, Bjorksten B. Phospholipid fatty acids in cord blood: family history and development of allergy. Acta Paediatrica 1996;85:679-83. 72. Newson RB, Shaheen SO, Henderson AJ, Emmett PM, Sherriff A, Calder PC. Umbilical cord and maternal blood red cell fatty acids and early childhood wheezing and eczema. J Allergy Clin Immunol 2004;114:531-7. 73. Morar N, Willis-Owen SAG, Moffatt MF, Cookson WOCM. The genetics of atopic dermatitis. J Allergy Clin Immunol 2006;118:24-34; quiz 5-6. 74. Smith FJD, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006;38:337-42. 75. Palmer CNA, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6. 76. Barker JNWN, Palmer CNA, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007;127:564-7. 77. Marenholz I, Nickel R, Ruschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006;118:866-71. 78. Morar N, Cookson WOCM, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007;127:1667-72. 79. Ruether A, Stoll M, Schwarz T, Schreiber S, Folster-Holst R. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. British Journal of Dermatology 2006;155:1093-4. 80. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007;39:650-4. 81. Stemmler S, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 2007;127:722-4. 82. Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations.[Erratum appears in J Allergy Clin Immunol. 2006 Oct;118(4):922], [Erratum appears in J Allergy Clin Immunol. 2006 Sep;118(3):724]. J Allergy Clin Immunol 2006;118:214-9. 83. Weidinger S, Rodriguez E, Stahl C, et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007;127:724-6. 84. Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27:372-3. 85. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J Invest Dermatol 1996;106:989-92. 86. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nature Reviews Molecular Cell Biology 2005;6:328-40. 87. Presland RB, Dale BA. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Critical Reviews in Oral Biology & Medicine 2000;11:383-408. 88. Irvine AD. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007;127:504-7. 89. Baurecht H, Irvine AD, Novak N, et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007;120:1406-12. 90. van den Oord RAHM, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009;339:b2433. 91. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63-8. 92. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends in Genetics 2004;20:350-8. 93. Burdge GC, Slater-Jefferies J, Torrens C, Phillips ES, Hanson MA, Lillycrop KA. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. British Journal of Nutrition 2007;97:435-9. 94. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility.[Erratum appears in Science. 2010 May 7;328(5979):690]. Science 2005;308:1466-9. 95. Nightingale KP, O'Neill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Current Opinion in Genetics & Development 2006;16:125-36. 96. Chmurzynska A. Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutrition Reviews 2010;68:87-98. 97. Miller RL, Ho S-M. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 2008;177:567-73. 98. Rubin MM. Antenatal exposure to DES: lessons learned...future concerns. Obstetrical & Gynecological Survey 2007;62:548-55. 99. Edwards TM, Myers JP. Environmental exposures and gene regulation in disease etiology. Environmental Health Perspectives 2007;115:1264-70. 100. Perera F, Tang W-y, Herbstman J, et al. Relation of DNA methylation of 5'-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma.[Erratum appears in PLoS One. 2009;4(8). doi: 10.1371/annotation/6a678269-9623-4a13-8b19-4e9431ff3cb6]. PLoS ONE [Electronic Resource] 2009;4:e4488. 101. O'Connell EJ. The burden of atopy and asthma in children. Allergy 2004;59 Suppl 78:7-11. 102. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010;65:152-67. 103. Arima K, Umeshita-Suyama R, Sakata Y, et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002;109:980-7. 104. Cameron L, Webster RB, Strempel JM, et al. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol 2006;177:8633-42. 105. Wang M, Xing Z-M, Lu C, et al. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet 2003;113:387-90. 106. Hunninghake GM, Soto-Quiros ME, Avila L, et al. Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol 2007;120:84-90. 107. Liu X, Beaty TH, Deindl P, et al. Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: The German Multicenter Atopy Study. J Allergy Clin Immunol 2003;112:382-8. 108. Sadeghnejad A, Karmaus W, Hasan Arshad S, Ewart S. IL13 gene polymorphism association with cord serum immunoglobulin E. Pediatr Allergy Immunol 2007;18:288-92. 109. Liu C-A, Wang C-L, Chuang H, Ou C-Y, Hsu T-Y, Yang KD. Prediction of elevated cord blood IgE levels by maternal IgE levels, and the neonate's gender and gestational age. Chang Gung Med J 2003;26:561-9. 110. Diaz-Sanchez D, Rumold R, Gong H, Jr. Challenge with environmental tobacco smoke exacerbates allergic airway disease in human beings. J Allergy Clin Immunol 2006;118:441-6. 111. Noakes PS, Holt PG, Prescott SL. Maternal smoking in pregnancy alters neonatal cytokine responses. Allergy 2003;58:1053-8. 112. Sadeghnejad A, Karmaus W, Arshad SH, Kurukulaaratchy R, Huebner M, Ewart S. IL13 gene polymorphisms modify the effect of exposure to tobacco smoke on persistent wheeze and asthma in childhood, a longitudinal study. Respir Res 2008;9:2. 113. Bonnin AJ, Montealegre F, Gewurz A. Association of cigarette smoking with elevated serum IgE levels in Hispanic Puerto Rican men. Ann Allergy 1991;67:609-11. 114. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. 115. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 1998;15:173-81. 116. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002;53:79-91. 117. Hong X, Tsai H-J, Liu X, et al. Does genetic regulation of IgE begin in utero? Evidence from T(H)1/T(H)2 gene polymorphisms and cord blood total IgE. J Allergy Clin Immunol 2010;126:1059-67. 118. Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008;63:1418-27. 119. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76. 120. Verhoeff AP, van Strien RT, van Wijnen JH, Brunekreef B. Damp housing and childhood respiratory symptoms: the role of sensitization to dust mites and molds. American Journal of Epidemiology 1995;141:103-10. 121. Yang CY, Tien YC, Hsieh HJ, Kao WY, Lin MC. Indoor environmental risk factors and childhood asthma: a case-control study in a subtropical area. Pediatric Pulmonology 1998;26:120-4. 122. Tham KW, Zuraimi MS, Koh D, Chew FT, Ooi PL. Associations between home dampness and presence of molds with asthma and allergic symptoms among young children in the tropics. Pediatr Allergy Immunol 2007;18:418-24. 123. Chen C-H, Lee YL, Wu M-H, et al. Environmental tobacco smoke and male sex modify the influence of IL-13 genetic variants on cord blood IgE levels. Pediatr Allergy Immunol 2012;in press. 124. Wuthrich B, Schindler C, Medici TC, Zellweger JP, Leuenberger P. IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team. Int Arch Allergy Immunol 1996;111:396-402. 125. Kabesch M, Schedel M, Carr D, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006;117:269-74. 126. Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. American Journal of Epidemiology 2008;168:212-24. 127. Sternthal MJ, Coull BA, Chiu Y-HM, Cohen S, Wright RJ. Associations among maternal childhood socioeconomic status, cord blood IgE levels, and repeated wheeze in urban children. J Allergy Clin Immunol 2011;128:337-45.e1. 128. Reponen T, Singh U, Schaffer C, et al. Visually observed mold and moldy odor versus quantitatively measured microbial exposure in homes. Science of the Total Environment 2010;408:5565-74. 129. Cai GH, Bröms K, Mälarstig B, et al. Quantitative PCR analysis of fungal DNA in Swedish day care centers and comparison with building characteristics and allergen levels. Indoor Air 2009;19:392-400. 130. Hsu NY, Wang JY, Su HJ. A dose-dependent relationship between the severity of visible mold growth and IgE levels of pre-school-aged resident children in Taiwan. Indoor Air 2010;20:392-8. 131. Tsai CH, Tung KY, Chen CH, Lee YL. Tumour necrosis factor G-308A polymorphism modifies the effect of home dampness on childhood asthma. Occupational and Environmental Medicine 2011;68:771-6. 132. Tischer CG, Hohmann C, Thiering E, et al. Meta-analysis of mould and dampness exposure on asthma and allergy in eight European birth cohorts: an ENRIECO initiative. Allergy 2011;66:1570-9. 133. Tischer C, Chen CM, Heinrich J. Association between domestic mould and mould components, and asthma and allergy in children: a systematic review. Eur Respir J 2011;38:812-24. 134. Denis O, van den Brûle S, Heymans J, et al. Chronic intranasal administration of mould spores or extracts to unsensitized mice leads to lung allergic inflammation, hyper-reactivity and remodelling. Immunology 2007;122:268-78. 135. Chung YJ, Copeland LB, Doerfler DL, Ward MDW. The relative allergenicity of Stachybotrys chartarum compared to house dust mite extracts in a mouse model. Inhalation Toxicology 2010;22:460-8. 136. Kim BS, Park S-M, Uhm TG, et al. Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics 2010;20:748-58. 137. Rylander R, Lin RH. (1-->3)-beta-D-glucan - relationship to indoor air-related symptoms, allergy and asthma. Toxicology 2000;152:47-52. 138. Altamura M, Casale D, Pepe M, Tafaro A. Immune responses to fungal infections and therapeutic implications. Current Drug Targets - Immune Endocrine & Metabolic Disorders 2001;1:189-97. 139. Rylander R. Organic dust induced pulmonary disease - the role of mould derived beta-glucan. Annals of Agricultural & Environmental Medicine 2010;17:9-13. 140. Schedel M, Frei R, Bieli C, et al. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression. J Allergy Clin Immunol 2009;124:583-9. 141. Schedel M, Carr D, Klopp N, et al. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol 2004;114:1100-5. 142. Blease K, Schuh JM, Jakubzick C, et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. American Journal of Pathology 2002;160:481-90. 143. Belsky J, Jonassaint C, Pluess M, Stanton M, Brummett B, Williams R. Vulnerability genes or plasticity genes? Molecular Psychiatry 2009;14:746-54. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16373 | - |
dc.description.abstract | The dissertation includes a review for cord blood biomarkers and a research on predictors of cord blood IgE elevation. The review aimed to evaluate the importance of cord blood biological markers in predicting the development of childhood atopic dermatitis. Two sub-studies were conducted to investigate the association of genetic variants of the IL-13, IL-4, and STAT6 genes from the cord blood and the association of prenatal environmental factors with cord blood IgE (cIgE) elevation, and to examine the influences of the potential gene by environment interactions on cIgE level in a population of Taiwanese term neonates.
Review. Biological markers in cord blood to predict atopic dermatitis in childhood Atopic dermatitis, a chronic inflammatory skin disease that usually occurs in the first few years of life, is an important risk factor for the subsequent development of asthma. While genetic and early environmental risk factors for expression of atopic dermatitis have been widely investigated and reviewed, relatively little attention has been paid to whether different biologic compositions of cord blood could increase or reduce the risk of developing atopic dermatitis in childhood. At birth, collection of cord blood is an easy and non-invasive procedure. This mini-review attempts to search and evaluate which biomarkers in cord blood may be able to predict atopic dermatitis in childhood. Among studies related to this issue, most showed inconsistent or contradictory results. The biological markers which have been studied in cord blood include IgE, T helper 1 and T helper 2 cytokines, macrophage inflammatory protein β (MIP-1β), and fatty acids. Among them, IL-13 responses and MIP-1β in cord blood may be important predictors for the development of atopic dermatitis in childhood. Although many studies recognized the mutations of filaggrin gene (FLG) as major genetic determinants for atopic dermatitis, none of these studies detected FLG from the cord bloods. Moreover, epigenetic modification perhaps is another substantial predictor for atopic dermatitis, but the association between them remains unclear. To verify the significance of previously examined biomarkers and to identify new biological predictor in cord blood, such as FLG mutations or epigenetic modifications, a large-scaled birth cohort design is needed. Study I. Environmental tobacco smoke and male sex modify the influence of IL-13 genetic variants on cord blood IgE levels Elevated cord blood IgE (cIgE) levels enhance the risk of childhood atopic diseases. However, genetic determinants of cIgE elevation and their potential modifiers remain inconclusive. We aimed to investigate the associations of single nucleotide polymorphisms (SNPs) in the IL-13 gene (IL-13) with cIgE elevation and their interactions with prenatal environmental tobacco smoke (ETS) and neonatal sex. A structured questionnaire regarding prenatal environmental exposures was completed during pregnancy. Birth information was extracted from the medical records. Cord blood from 794 term neonates were genotyped for three SNPs (rs1800925, rs20541, and rs848) of IL-13 and measured for cIgE levels. SNP rs20541 and a 3-SNP haplotype containing rs1800925, rs20541, and rs848 (denoted as h011) were significantly associated with cIgE elevation (p = 0.04 and 0.003, respectively). Two-way interaction analysis revealed that the associations of IL-13 rs20541 and h011 with cIgE elevation were synergistically enhanced by prenatal ETS (p for interaction = 0.03 and 0.03, respectively), but not by male sex. If the association analyses were stratified by prenatal ETS and neonatal sex simultaneously, IL-13 rs20541 and h011 had the highest risks for cIgE elevation in male babies prenatally exposed to ETS, with adjusted odds ratios (95% confidence interval) being 3.03 (1.56-5.88) and 2.81 (1.54-5.15), respectively. When three-way interactions were examined, both IL-13 rs20541 and h011 exhibited significant interactions with male sex and ETS (p for interaction = 0.03 and 0.007, respectively). In conclusion, the influence of IL-13 genetic variants on cIgE elevation was modified by male sex and prenatal ETS. Study II. Sex-modified interaction between IL4/IL13 pathway genes and prenatal household environment on cord blood IgE levels Elevated cord blood IgE (cIgE), a predictor of childhood atopic diseases, is influenced by genetic and environmental factors. However, gene-environment interactions on cIgE elevation and their difference by sex remain largely unexplored. We aimed to determine if there are interactions between genetic variants in the IL4/IL13 pathway and prenatal household environments on cIgE elevation, and if such interactions are modified by sex. In 1107 Han-Chinese mother-fetus pairs, comprehensive information on environmental tobacco smoke (ETS), home dampness (indexed by combining mildewy odor, visible mold, and water stamp on the wall), and other prenatal household environments was obtained using a structured questionnaire during the third trimester of pregnancy. Cord blood was collected for measuring cIgE levels, with elevation defined as > or = 0.5 IU/mL, and for genotyping of five single nucleotide polymorphisms (IL-13 rs1800925, rs20541, rs848, IL-4 rs2243250, and STAT6 rs324011) of three candidate genes. Several gene-environment interactions on cIgE elevation in neonatal sex-stratified analyses were observed only in male newborns, including those between ETS and IL13 rs20541, between cumulative home dampness and STAT6 rs324011, and between composite environmental exposures (combined ETS and the three home dampness indices) and STAT6 rs324011 (P for interaction = .03, .006, and .001, respectively). Only male newborns carrying particular genotypes of IL4/IL13 pathway genes manifested with dose-response effects of prenatal environments on cIgE elevation. In conclusion, male sex modifies the gene-environment interactions involving IL4/IL13 pathway genes and prenatal household environments for cIgE production. | en |
dc.description.provenance | Made available in DSpace on 2021-06-07T18:11:56Z (GMT). No. of bitstreams: 1 ntu-101-D97842002-1.pdf: 802128 bytes, checksum: 8d77259831661d7edb68f78d762b1f36 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 口試委員會審定書 i
中文摘要 .ii Abstract v List of tables xi List of figures xiii Chapter 1 Overview 1 Chapter 2 Review: Biological markers in cord blood to predict atopic dermatitis in childhood 4 Introduction 4 Prenatal factors to influence cord blood biomarkers 5 Biomarkers in cord blood to predict atopic dermatitis 6 Novel Biomarkers and their potentials 11 Conclusions 14 Table……………..….. 16 Chapter 3 Study I — Environmental tobacco smoke and male sex modify the influence of IL-13 genetic variants on cord blood IgE levels……...………………………………………………… 18 Introduction 18 Methods 20 Results 23 Discussion 27 Tables and figures .. 32 Chapter 4 Study II — Sex-modified interaction between IL4/IL13 pathway genes and prenatal household environment on cord blood IgE levels……………………………………………..40 Introduction 40 Methods ……………………………………………………………41 Results 44 Discussion 47 Tables and figures 53 Chapter 5 Conclusion and Perspective……………………………65 References………………………………………………………………67 | |
dc.language.iso | en | |
dc.title | 臍帶血免疫球蛋白E升高的預測因子: 基因、產前居家環境、與受性別修飾之基因-環境交互作用 | zh_TW |
dc.title | Predictors of Cord Blood IgE Elevation: Genes, Prenatal Household Environment, and Sex-Modified Gene-Environment Interactions | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 黃嵩立,李文宗,林于粲,郭柏秀 | |
dc.subject.keyword | 臍帶血,免疫球蛋白E,單核苷,酸多型性,產前環境,性別, | zh_TW |
dc.subject.keyword | cord blood,IgE,single nucleotide polymorphism,prenatal environment,sex, | en |
dc.relation.page | 87 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2012-06-28 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 783.33 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。